|
|
Clinical distribution and drug resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis infection in Yangjiang People′s Hospital in 2019 |
HE Guo-hua CHEN Dong-ling LI Qing-mei CHEN Jin-ling LI Shuai YANG Li-ping |
Department of Clinical Laboratory,Yangjiang People′s Hospital,Guangdong Province,Yangjiang 529500,China |
|
|
Abstract Objective To analyze the clinical distribution and drug resistance characteristics of Mycoplasma detected in our hospital in 2019 to provide basis for the rational use of antibiotics.Methods The gender ratio,age distribution,department distribution and drug resistance of Ureaplasma urealyticum (Uu) and Mycoplasma hominis (Mh) detected in our hospital in 2019 were analyzed retrospectively.Results A total of 1300 cases (169 males and 1131 females) of Uu and 161 cases (6 males and 155 females) of Mh were detected in 2019.Mycoplasma was distributed in all age groups,Uu was mostly detected in ≤25 years old patient group.In terms of department distribution,the departments were mainly concentrated in gynecology(Uu:64.77%,Mh: 75.16%),obstetrics (Uu: 9.23%,Mh: 10.56%),urology (Uu: 10.54%,Mh: 3.73%),reproductive medicine (Uu: 8.31%,Mh: 3.73%),other departments accounted for less.Drug sensitivity results showed that Uu had a strong sensitivity to Doxycycline,Fulminomycin,Acrosamycin,Clarithromycin,Azithromycin,with the sensitivity rates of 92.69%,93.00%,97.69%,88.69%,77.23%,respectively,while Mh was more sensitive to Doxycycline,Fulminomycin,Acrosamycin,with the sensitivity rates of 86.33%,86.96%,91.3%.Conclusion The Mycoplasma infection detected in our hospital is mainly Uu,the antibiotics should be used according to the results of clinical drug sensitivity in clinical departments.
|
|
|
|
|
[1] |
王辉,任健康,王明贵.临床微生物学检验[M].北京:人民卫生出版社,2015.
|
[2] |
Lis R,Rowhanirahbar A,Manhart LE.Mycoplasma genitalium infection and female reproductive tract disease:a metaanalysis[J].Clin Infect Dis,2016,61(3):418-426.
|
[3] |
Gimenes F,Souza RP,Bento JC,et al.Male infertility:a public health issue caused by sexually transmitted pathogens[J].Nature Rev Urol,2014,11(12):672-687.
|
[4] |
冯维.2013~2017年泌尿生殖道解脲支原体感染状况耐药性变迁分析[J].现代实用医学,2019,31(6):764-765.
|
[5] |
胡枫,詹燏,刘芳,等.泌尿生殖道感染支原体的分布和耐药性变迁分析[J].中国医院药学杂志,2019,39(17):1791-1793.
|
[6] |
尚红,王毓三,申子瑜.全国临床检验操作规程[M].4版.北京:人民卫生出版社,2014.
|
[7] |
李菊萍.解脲支原体、人型支原体对宫颈炎影响研究[J].临床军医杂志,2019,47(6):654-656.
|
[8] |
郑蔓嘉,张景春,陈洁丽,等.解脲支原体感染与盆腔炎的关系[J].海南医学,2019,30(3):367-369.
|
[9] |
史恒芳,朱芝娴,王恒.支原体感染对精液质量影响及支原体分型和耐药分析[J].航空航天医学杂志,2018,29(10):1195-1199.
|
[10] |
张育超.男性解脲脲原体感染对精液质量的影响[J].内蒙古医学杂志,2019,51(4):447-448.
|
[11] |
宋伟杰,刘心怡,刘建业,等.解脲支原体感染对表征男性精子质量关键参数影响的全面分析[J].中国男科学杂志,2019,33(6):32-35.
|
[12] |
邓思.解脲支原体、沙眼衣原体感染与复发性自然流产的相关性[J].临床医学,2018,38(12):37-38.
|
[13] |
罗蓓,童笑梅.围生期解脲脲原体感染的研究进展[J].中国儿童保健杂志,2019,27(6):620-623.
|
[14] |
尧荣凤,李智,沈菊英,等.泌尿生殖道支原体药物敏感性试验结果动态分析[J].检验医学,2016,31(12):1050-1054.
|
[15] |
周景欣.泌尿生殖道解脲支原体和人型支原体感染情况及药敏结果分析[J].中国微生态学杂志,2017,29(3):338-340.
|
[16] |
刘力娟,王厚芳,孙芾.泌尿生殖道支原体培养与药敏结果分析[J].中国当代医药,2019,26(3):146-149.
|
[17] |
王晓娜,丛桂敏,曹作伟,等.连续5年沈阳地区生殖道支原体感染监测及耐药性变迁[J].当代医学,2020,26(6):20-23.
|
[18] |
王薇华,李丽莎,陈华辉,等.女性生殖道解脲支原体感染与配偶预防治疗的临床观察[J].中国计划生育和妇产科,2020,12(2):62-68.
|
|
|
|